Article: Ibrutinib: a major breakthrough in the treatment of chronic lymphocytic leukaemia (CLL) and other lymphoproliferative disorders

2.42

SKU: product-article-21008 Category:

Description

Ibrutinib: a major breakthrough in the treatment of chronic lymphocytic leukaemia (CLL) and other lymphoproliferative disorders

Reviews

There are no reviews yet.

Be the first to review “Article: Ibrutinib: a major breakthrough in the treatment of chronic lymphocytic leukaemia (CLL) and other lymphoproliferative disorders”

Your email address will not be published. Required fields are marked *